about
Improvement of the nailfold capillaroscopy after immunosuppressive treatment in polymyositis.Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune DiseasesCalcium dysregulation, functional calpainopathy, and endoplasmic reticulum stress in sporadic inclusion body myositis.The 'sparing phenomenon' of purpuric rash over tattooed skin.Diagnosis and classification of eosinophilic fasciitis.Inflammatory myopathy: diagnosis and clinical course, specific clinical scenarios and new complementary tools.Spectrum of immune-mediated necrotizing myopathies and their treatments.Statin-associated autoimmune myopathy: A distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories.IgG4-related disease: Evidence from six recent cohorts.High-resolution manometry in patients with idiopathic inflammatory myopathy: Elevated prevalence of esophageal involvement and differences according to autoantibody status and clinical subset.Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease.Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.Lung transplantation in systemic sclerosis: A single center cohort study.A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies.Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients.RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositisCardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival.Statin-Induced Anti-HMGCR-Associated Myopathy.[Chest pain of 48 hours of evolution in a 41 years-old man].Giant aortic aneurysm in Marfan syndrome.Opportunistic infections in patients with idiopathic inflammatory myopathies.Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.Antisynthetase antibodies in World Trade Center rescue and recovery workers with inflammatory myositis: comment on the article by Webber et al.Health-related quality of life and well-being in adults with idiopathic inflammatory myopathy.Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis.Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index.Fast 1.5 T chest MRI for the assessment of interstitial lung disease extent secondary to systemic sclerosis.Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome.Mixed Connective Tissue Disease and Epitope Spreading: An Historical Cohort Study.More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients.Immune-Mediated Necrotizing Myopathy.Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.Correlation of ultrasound B-lines with high-resolution computed tomography in antisynthetase syndrome.The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis.Histiocytoid Sweet syndrome and cutaneous polyarteritis nodosa secondary to myelodysplastic syndrome.Statins: pros and cons.The diagnostic work-up of cancer-associated myositis“Pregnancy in adult-onset idiopathic inflammatory myopathy”: Report from a cohort of myositis patients from a single center
P50
Q36794148-0F5CAAA7-9D54-495E-931D-595A1AF467CEQ36953554-6580B5D7-CEF3-479F-9D72-27B06D980340Q37717548-FAF13E15-4050-4E12-8743-E2DFEECA78CAQ38172802-015AA637-70D3-4C2F-8C4F-8BF190C6610CQ38178473-5ABC872C-82A4-44A8-9AEA-8B344F6A1BF2Q38450473-2C8F5EBA-DF8C-4313-96F2-251F81CD212DQ38949362-0A473300-D9AF-4525-B7C7-6B2A2A1F6E6DQ38957797-3285A121-2566-4F18-9E45-312E02206610Q39042303-EA495E0F-1D21-4A23-B38C-A9E98F50E8B8Q39116064-8BCECEE4-0553-4381-86F0-8C0E466CBE64Q39776324-F2BC654F-091D-4790-A3E7-97AA40C91862Q39824090-1316D4D6-5A46-4C6A-87AE-38D435709DADQ40251508-C1DD9C56-4B6D-4BD1-9113-7EA243DD7111Q40275221-A6B18088-6651-484F-BA5E-08BF8E6DC397Q40298726-4E7F3CC7-3A29-4957-886C-033AB7934694Q41111946-3C1E8ED2-A72C-4C9B-8355-9E8747A9DC15Q41189863-FE714AE6-0B19-476C-A655-CBF7028042F1Q42255031-5BA08CA7-5CA0-440F-AA87-E5177F8C1D81Q46066613-CB308F40-0225-4424-B07E-4F5793A599C6Q46107354-BA118EB6-22E0-48A3-B458-1CB1DA657D04Q47556705-FFD6F6DC-13F8-440E-A9BC-F30B993FE728Q47648163-A6357D42-5600-4453-8229-E656F7CFAA55Q48018673-373D38B1-1BF0-4300-9DB5-D9139AABE99CQ48074182-60D11671-EDCE-446C-A867-6808E59D1CB3Q48344148-B2757FE3-615D-4832-BCF7-3A8AA02EF1DCQ49921821-8758F8D8-B009-4817-9FB6-AD2C0A5E453BQ49922890-10D4C210-8F87-4AE6-A399-6411FCEAB807Q50660360-42E929AF-CE29-45A6-843B-855BDC0F83E7Q50862065-C1E59B4A-A67B-4037-BE73-6D326926A4A4Q50867176-F0E6AE37-F118-410C-82C8-097A8F08E536Q50948932-0AD6375B-E6F8-4633-B57E-55AE3AC3C755Q51192752-9676D689-679C-45D6-B974-83221257961FQ52628910-436AC225-B6AA-4185-A6AA-4A6A14F81D33Q52688656-5F462882-908F-4BF8-8072-2F30E33D631CQ53067815-EE05C18B-2849-48FD-81DF-12CFCBBC1056Q53319680-B1E57192-E74B-4007-8F05-5618C944CA29Q54380189-5337C533-3B6B-4749-B748-FE8DB9F40133Q55312692-4D4A9029-E12B-4E02-893B-231260AEDBCEQ57129048-2F664950-FFE0-4C1D-951C-DE73F20811F6Q57942192-257642B5-01A6-4B45-8CBA-D5192C96925C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Iago Pinal-Fernandez
@ast
Iago Pinal-Fernandez
@en
Iago Pinal-Fernandez
@es
Iago Pinal-Fernandez
@nl
Iago Pinal-Fernandez
@sl
type
label
Iago Pinal-Fernandez
@ast
Iago Pinal-Fernandez
@en
Iago Pinal-Fernandez
@es
Iago Pinal-Fernandez
@nl
Iago Pinal-Fernandez
@sl
prefLabel
Iago Pinal-Fernandez
@ast
Iago Pinal-Fernandez
@en
Iago Pinal-Fernandez
@es
Iago Pinal-Fernandez
@nl
Iago Pinal-Fernandez
@sl
P106
P1153
36895096800
P31
P496
0000-0001-6338-9218